205 related articles for article (PubMed ID: 19069677)
21. Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia.
Skoumas J; Papadimitriou L; Pitsavos C; Masoura C; Giotsas N; Chrysohoou C; Toutouza M; Panagiotakos D; Stefanadis C
Metabolism; 2007 Jan; 56(1):135-41. PubMed ID: 17161236
[TBL] [Abstract][Full Text] [Related]
22. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
23. PAI-1 levels are related to insulin resistance and carotid atherosclerosis in subjects with familial combined hyperlipidemia.
Carratala A; Martinez-Hervas S; Rodriguez-Borja E; Benito E; Real JT; Saez GT; Carmena R; Ascaso JF
J Investig Med; 2018 Jan; 66(1):17-21. PubMed ID: 28822973
[TBL] [Abstract][Full Text] [Related]
24. Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.
van der Vleuten GM; Veerkamp MJ; van Tits LJ; Toenhake H; den Heijer M; Stalenhoef AF; de Graaf J
Atherosclerosis; 2005 Dec; 183(2):355-60. PubMed ID: 16285998
[TBL] [Abstract][Full Text] [Related]
25. Melatonin-insulin interactions in patients with metabolic syndrome.
Robeva R; Kirilov G; Tomova A; Kumanov P
J Pineal Res; 2008 Jan; 44(1):52-6. PubMed ID: 18078448
[TBL] [Abstract][Full Text] [Related]
26. TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome.
Gwozdziewiczová S; Lichnovská R; Ben Yahia R; Chlup R; Hrebícek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):109-17. PubMed ID: 16170397
[TBL] [Abstract][Full Text] [Related]
27. [Expression of glucagon in gestational and diet-induced hyperlipidemic gestational rats].
Wang L; Cao HW; Zhang J; Tang CW; Ji QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):359-62. PubMed ID: 20368116
[TBL] [Abstract][Full Text] [Related]
28. Soluble cell adhesion molecules s-VCAM-1 and s-ICAM-1 in subjects with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Budíková M; Novotný D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):101-8. PubMed ID: 16170396
[TBL] [Abstract][Full Text] [Related]
29. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
30. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
[TBL] [Abstract][Full Text] [Related]
31. Androgenetic alopecia and insulin resistance in young men.
González-González JG; Mancillas-Adame LG; Fernández-Reyes M; Gómez-Flores M; Lavalle-González FJ; Ocampo-Candiani J; Villarreal-Pérez JZ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):494-9. PubMed ID: 19094069
[TBL] [Abstract][Full Text] [Related]
32. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
33. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
[TBL] [Abstract][Full Text] [Related]
34. [Genetic factors in familial combined hyperlipidemia and insulin resistance syndrome associated with dyslipidemia].
Moulin P
Ann Endocrinol (Paris); 1997; 58(4):287-91. PubMed ID: 9436476
[TBL] [Abstract][Full Text] [Related]
35. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Taskinen MR; Deeb SS; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1789-95. PubMed ID: 10894818
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia.
Meex SJ; van der Kallen CJ; van Greevenbroek MM; Eurlings PM; El Hasnaoui M; Evelo CT; Lindsey PJ; Luiken JJ; Glatz JF; de Bruin TW
FASEB J; 2005 Dec; 19(14):2063-5. PubMed ID: 16219805
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
Koca SS; Karaca I; Yavuzkir MF; Dağli N; Ozgen M; Ustündağ B; Işik A
Anadolu Kardiyol Derg; 2009 Feb; 9(1):23-8. PubMed ID: 19196569
[TBL] [Abstract][Full Text] [Related]
38. Concordant dyslipidemia, hypertension and early coronary disease in Utah families.
Williams RR; Hunt SC; Wu LL; Hopkins PN; Hasstedt SJ; Schumacher MC; Stults BM; Kuida H
Klin Wochenschr; 1990; 68 Suppl 20():53-9. PubMed ID: 2189041
[TBL] [Abstract][Full Text] [Related]
39. [Familial combined hyperlipidemia, metabolic syndrome and cardiovascular disease].
Martinez-Hervás S; Real JT; Priego A; Sanz J; Martín JM; Carmena R; Ascaso JF
Rev Esp Cardiol; 2006 Nov; 59(11):1195-8. PubMed ID: 17144994
[TBL] [Abstract][Full Text] [Related]
40. Paraoxonase (PON1) is associated with familial combined hyperlipidemia.
van Himbergen TM; van Tits LJ; Ter Avest E; Roest M; Voorbij HA; de Graaf J; Stalenhoef AF
Atherosclerosis; 2008 Jul; 199(1):87-94. PubMed ID: 18096166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
